Kyungnam set to join prescription market

Published: 2008-09-25 06:53:00

Updated: 2008-09-25 06:53:00

Kyungnam Pharm, a local OTC maker, has signed a memorandum of understanding with the Korean Association for Vitamin Research to develop DETOX (detoxication therapy), according to a company spokesperson.

The company plans to invest 20 billion won in the development of new drugs for five years.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK